![](/img/cover-not-exists.png)
Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: Results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain
Lynn Webster, Jan Peter Jansen, John Peppin, Ben Lasko, Gordon Irving, Bart Morlion, Jerry Snidow, Amy Pierce, Eric Mortensen, Christi Kleoudis, Eric CarterVolume:
137
Year:
2008
Language:
english
DOI:
10.1016/j.pain.2007.11.008
File:
PDF, 723 KB
english, 2008